Skip to content

Dr. Sarah Gils

Active
Private limited companyfounded 2021active for 5 yearsConstantin Meunierstraat 77, 3000 Leuven, BelgiumKBO/BCE: BE 0767.705.510
Summary

Dr. Sarah Gils has been active since 2021 and the Belgian Official Gazette contains no insolvency or warning signals. The 2025 annual accounts show equity of €3,000 and a net result of €192,554. Equity has been growing by about 56% per year since 2021. Its solvency ranks better than 5% of 20,700 sector peers (NACE 86, financial year 2025). The computed 12-month bankruptcy probability is below 0.1% (very low).

Overview

Official details

Source: KBO
Status
Active since 30-04-2021 Normal situation
Activity
Specialist medical practice NACE 86220and 1 other
Establishment unit
2.316.562.512 3000 Leuven, since 30-04-2021
Financial year end
31 December
Peppol
Reachable since 22-10-2025

Board and ownership

Board
  • Gils SarahDirector · since 30-04-2021

Financial position

91 Excellent Checked score 2025
Bankruptcy probabilitywithin 12 months
< 0.1%
Annual accounts 2025
Gross margin
€254,149
▲ 53.0%
Turnover
≈ €390,000
estimated
Profit
€192,554
▲ 51.5%
Equity
€3,000
▼ 99.4%
Total assets
€651,777
▲ 23.8%
Score breakdownraises riskEquity €3,000 (0.5% of total assets)lowers riskSector: Human health activities (NACE 86)Size: total assets €651,777Liquidity: current ratio 1.00, cash €646,925Show the evidence

Checked score

Score 2025
91 / 100
Excellent
Probability in this band: under 0.55%
Financially stronger than 27% of micro companies in human health (NACE 86)
Financial strength · tick: 2024
Average
Solvency 25-75
equity 0.5% of total assets
Liquidity 50-50
short-term debt 99.5% · cash 99.3%
Profitability 100+1
return on assets 29.5%
Bankruptcy probability within 12 months
< 0.1% Very low
0%0.5%1.5%4%10%≥ 25%

Fewer than 1 in 1,000 comparable companies go bankrupt within 12 months (an estimate).

Sector median < 0.1% (24,160 companies, NACE 86, micro)
Last 24 months 12-2024: < 0.1% 01-2025: < 0.1%● unchanged vs 12-2024lowest value 02-2025: < 0.1%● unchanged vs 01-2025 03-2025: < 0.1%● unchanged vs 02-2025 04-2025: < 0.1%● unchanged vs 03-2025 05-2025: < 0.1%● unchanged vs 04-2025 06-2025: < 0.1%● unchanged vs 05-2025 07-2025: < 0.1%● unchanged vs 06-2025 08-2025: < 0.1%● unchanged vs 07-2025 09-2025: < 0.1%● unchanged vs 08-2025 10-2025: < 0.1%● unchanged vs 09-2025 11-2025: < 0.1%● unchanged vs 10-2025 12-2025: < 0.1%● unchanged vs 11-2025 01-2026: < 0.1%● unchanged vs 12-2025 02-2026: < 0.1%● unchanged vs 01-2026 03-2026: < 0.1%● unchanged vs 02-2026 04-2026: < 0.1%● unchanged vs 03-2026 05-2026: < 0.1%● unchanged vs 04-2026 06-2026: < 0.1%● unchanged vs 05-2026 07-2026: < 0.1%● unchanged vs 06-2026 08-2026: < 0.1%● unchanged vs 07-2026 09-2026: < 0.1%● unchanged vs 08-2026 10-2026: < 0.1%● unchanged vs 09-2026highest value 11-2026: < 0.1%● unchanged vs 10-2026highest value
Calculation

The band follows from the bankruptcy probability. 10 more points roughly halve it.

75-100 Excellent under 0.55%
60-74 Healthy 0.55% to 1.5%
45-59 Fair 1.5% to 4.2%
25-44 Weak 4.2% to 15.0%
0-24 Critical over 15.0%

Where the company stands within its band depends half on the bankruptcy probability and half on how it does against its sector peers (NACE 86, micro). It does better than 5% of them on solvency, 20% on liquidity, 80% on profitability and 2% on growth.

The bankruptcy probability was computed on 01-11-2026 by the bankruptcy model of 2 October 2026, which learns from Belgian bankruptcies and reads the registers, the annual accounts and the Belgian Official Gazette.

Some facts cap the score, however low the probability. With negative or zero equity, a heavy loss, a special status in the KBO, one missing filing or accounts filed more than 90 days late, the score is Fair at most (59). With two missing filings, it is Weak at most (44). During a judicial reorganisation or at the company's end (bankruptcy, dissolution, liquidation), it is Critical at most (24).

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Six signals.
lowers riskraises riskneutral
lowers risk · Sector: Human health activities (NACE 86)
KBO
lowers risk · Size: total assets €651,777
Companies of this size fail less often. How much that weighs depends on the rest of the company's profile.
NBB · annual accounts
raises risk · Equity €3,000 (0.5% of total assets)
NBB · annual accounts
lowers risk · Liquidity: current ratio 1.00, cash €646,925
NBB · annual accounts
raises risk · Weak solvency compared with the sector
Solvency (equity / total assets) is in the sector's weakest quartile: better than 5% of 20700 sector peers (2025).
NBB · sector comparison
Position among 20700 sector peers
Solvency
better than 5%
← weakest strongest →
neutral · Latest accounts filed on time
The financial year that closed on 31-12-2025 was due by 31-07-2026 and was filed on 29-06-2026, 32 days ahead of the deadline.
NBB · 5 filings
Deviation from the deadline
2025
32 days early
2024
31 days early
2023
37 days early
2022
11 days late
2021
24 days late
← before the deadline after the deadline →
tick = median of all Belgian filingsring = median in the sector

The company filed its last 5 accounts on average 13 days before the deadline. In the sector (NACE 86), the median for financial year 2024 was 7 days before the deadline, and 36% of those companies filed late.

Searched, nothing found (2)
neutral · Next filing not due yet
The next financial year closes on 31-12-2026 and is due by 31-07-2027. Nothing is late today. The company usually files around 30 June (4 of the last 5 accounts filed within 42 days either side of that date).
Companies Code · seven months
Where today falls in the filing period
02-11-2026 today31-12-2026 year end31-07-2027 deadline
neutral · No strike-offs in the KBO publications
That holds for every publication since 2021.
KBO publications

Key points

  • Caution: Equity fell in 2025from €526,046 to €3,000 ▼ 99.4% View
  • Caution: Lower solvency than 95% of companies in human healthsector median 63.0% · 20,700 companies 0.5% View
  • Positive: 5 profitable years in a rowprofit 2025: €192,554 5 years View

Recent changes

  1. · Gazette deed Incorporation
All 10 events

Comparable companies

These companies have the same main activity as Dr. Sarah Gils: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €614,000 and €650,000, founded between 2021 and 2022.

CompanyTotal assetsGross margin
Dr. Sarah Gils Leuven€651,777€254,149
Fysigo Bertem€621,790€258,967
Medimage Bierbeek€632,108€252,152
DR. BEN BROOS, ENDOCRINOLOOG Brasschaat€643,212€266,222
REVALIN Oudenburg€635,026€258,078
DOGYN Ciney€614,333€241,965
DOKTER EVELIEN CLAESEN RADIOLOGIE Diepenbeek€649,535€228,823
Full comparison

Key facts about Dr. Sarah Gils

What is the company number of Dr. Sarah Gils?
The company number of Dr. Sarah Gils is 0767.705.510. The VAT number is the same number with BE in front: BE 0767.705.510.
Where is Dr. Sarah Gils based?
The registered office is at Constantin Meunierstraat 77, 3000 Leuven.Company details
What does Dr. Sarah Gils do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of Dr. Sarah Gils?
The legal form of Dr. Sarah Gils is Private limited company (BV).
When was Dr. Sarah Gils founded?
Dr. Sarah Gils was founded on 30-04-2021.
Is Dr. Sarah Gils still active?
Yes, Dr. Sarah Gils is an active enterprise in the KBO register.
What is the turnover of Dr. Sarah Gils?
The turnover in financial year 2025 is ≈ €390,000. This figure is estimated from the gross margin of €254,149 and 36 comparable companies (NACE 862). It probably lies between €350,000 and €490,000.Financials
Is Dr. Sarah Gils profitable?
In financial year 2025, Dr. Sarah Gils made a profit of €192,554.
Where can I find the annual accounts of Dr. Sarah Gils?
Dr. Sarah Gils filed 5 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of Dr. Sarah Gils due?
Dr. Sarah Gils must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.